Visit TheBody.com for Patient Education
You are not currently logged in.
Login
or
Register
Sign up for free e-mail/fax newsletters!
New CME/CE:
African Americans & HIV: New Developments in Clinical Management, by Adaora Adimora, M.D. >>
Delavirdine (Rescriptor)
Overview
|
News
|
Research
See also:
Adverse Events of HIV/HAART
|
Drug Interactions
The Basics
A Clinical Overview of Delavirdine (Rescriptor)
(Regularly Updated)
To read PDF,
click here
From
U.S. National Institutes of Health
Prescribing Information for Delavirdine (Rescriptor) (PDF)
(June 2006)
From Pfizer, Inc.
Drug Interactions: Delavirdine
(August 2004)
From
Project Inform
Research
Clinical Trials Using Delavirdine
(Regularly Updated)
U.S. and international trials currently recruiting.
From
U.S. National Institutes of Health
Literature Citations for Delavirdine
(Regularly Updated)
From
U.S. National Institutes of Health
Women and Pharmacology: Delavirdine Study
(March 2001)
In
Project Inform Perspective
, from
Project Inform
BROWSE ALL TOPICS:
Clinical Management
Clinical Management
Clinical Management Home
Antiretroviral Therapy
Complications of HIV/HAART
Research & Development
Clinical Trials
More ...
Conference Coverage
Conference Coverage
Conference Coverage Home
CROI 2008
IDSA 2007
ICAAC 2007
IAS 2007
Previous Conferences
Upcoming Conferences
More ...
Epidemiology
Epidemiology
Epidemiology Home
Global Statistics
U.S. and Canada
Africa
Asia
Latin America, Caribbean
Western Europe
More ...
Transmission & Basic Science
Transmission & Basic Science
Transmission Home
HIV Pathogensis & Immunology
HIV Prevention
HIV Testing
Other STDs
HIV History
More ...
Professional Development
Professional Development
Professional Development Home
Training Resources
Treatment Education
News & Analysis
More ...
Policy & Activism
Policy & Activism
Policy & Activism Home
AIDS Drug Assistance Programs
Ryan White CARE Act
FDA Drug Review & Approval
Resource-Limited Countries
More ...